GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
39.13
+0.91 (2.38%)
At close: Aug 13, 2025, 4:00 PM
38.79
-0.34 (-0.87%)
Pre-market: Aug 14, 2025, 9:18 AM EDT
GSK Revenue
GSK had revenue of 7.99B GBP in the quarter ending June 30, 2025, with 1.29% growth. This brings the company's revenue in the last twelve months to 31.63B, up 0.59% year-over-year. In the year 2024, GSK had annual revenue of 31.38B with 3.46% growth.
Revenue (ttm)
31.63B GBP
Revenue Growth
+0.59%
P/S Ratio
1.81
Revenue / Employee
460,898 GBP
Employees
68,629
Market Cap
78.50B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
| Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
| Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
| Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
| Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
GSK News
- 3 days ago - GSK's antibiotic drug gepotidacin gets priority review by FDA - Reuters
- 6 days ago - GSK to Receive $370 Million in U.S. Patent Litigation Settlement - WSJ
- 12 days ago - Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challenges - WSJ
- 13 days ago - Pharma Companies Should Immediately Cut Down Drug Prices, Trump Says - Forbes
- 13 days ago - Trump pressures 17 pharma CEOs to cut US drug prices - Reuters
- 13 days ago - Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days - CNBC
- 14 days ago - GSK plc (GSK) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - GSK in talks with Trump administration on U.S. drug pricing, CEO says - Reuters